Tidal Investments’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$253M Buy
4,982,000
+1,070,000
+27% +$49.9M 0.53% 27
2025
Q4
$115M Sell
3,912,000
-4,058,000
-51% -$110M 0.27% 68
2025
Q3
$206M Buy
7,970,000
+7,901,420
+11,521% +$220M 0.41% 37
2025
Q2
$10.3M Buy
68,580
+17,100
+33% +$450K 0.06% 312
2025
Q1
$3.08M Buy
51,480
+21,360
+71% +$758K 0.03% 521
2024
Q4
$1.33M Buy
30,120
+23,360
+346% +$1.12M 0.01% 873
2024
Q3
$419K Buy
6,760
+4,400
+186% +$404K ﹤0.01% 1459
2024
Q2
$60.2K Buy
2,360
+230
+11% +$29.1K ﹤0.01% 1762
2024
Q1
$1.49M Buy
2,130
+1,835
+622% +$185K 0.02% 683
2023
Q4
$226K Buy
+295
New +$24.8K 0.01% 1295

Other funds holding MRNA

Tidal Investments's MRNA Position: Q1 2026 in Review

Tidal Investments increased its Moderna (MRNA) stake by 501% in Q1 2026, buying an estimated $3.77M and bringing the position to 97,031 shares worth $4.76M. The position accounts for 0.01% of the portfolio, ranked #822.

Tidal Investments first reported a position in MRNA in Q4 2020 and has held it in 22 quarters since. The position peaked at $7.68M in Q4 2024. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Tidal Investments held 97,031 shares of Moderna worth $4.76M as of Q1 2026.
  • Tidal Investments bought 80,895 Moderna shares in Q1 2026, an estimated $3.77M.
  • Moderna made up 0.01% of Tidal Investments's portfolio in Q1 2026, its #822 holding.
  • Tidal Investments first reported a position in Moderna in Q4 2020 and has held it in 22 quarters since.
  • Tidal Investments's Moderna position peaked at $7.68M in Q4 2024.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.